Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / F•••• H••••••••• A•••••••• L••

S•• S••••••• Announces Acquisition of Long-Term Partner F•••• H••••••••• Advisors

Add-on acquisitionclosedadd-onannounced Jun 29, 2021closed Jun 29, 2021Fact
What happened
Target
F•••• H••••••••• A•••••••• L••
Platform
S•• S•••••••add-on basis: S•• S•••••••, LLC (“SSI” or the “Company”), a leading Life Sciences consultancy, announced today that they have acquired F•••• H••••••••• A•••••••• L•• (FHA), a leading Pharmacovigilance consultancy and long-time SSI collaborative partner. | S•• S•••••••, LLC is held by A••••• Capital Partners on its portfolio page; published on A••••• Capital Partners's own news page
Control
Control
Share acquired
unknown
Industry
healthcare / clinic, healthcare, pharma
Target location
MA, US
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
6 named
Buy side
  • A•• U•••••••••Deal partnerconfirmed
    “A•• U•••••••••, Principal at A••••• stated, “The acquisition of FHA aligns with S•• S•••••••’s growth goals and aim to expand strategic services to support Medical, Clinical and Drug Safety functions at the C-level of Life Sciences companies.”
  • S•• S•••••••Platformconfirmed
    “S•• S•••••••, LLC (“SSI” or the “Company”), a leading Life Sciences consultancy, announced today that they have acquired F•••• H••••••••• A•••••••• L•• (FHA), a leading Pharmacovigilance consultancy and long-time SSI collaborative partner. | S•• S•••••••, LLC is held by A••••• Capital Partners on it”
  • A••••• C•••••• P•••••••• L•••Sponsorconfirmed
    “S•• S•••••••, LLC (“SSI” or the “Company”), a leading Life Sciences consultancy, announced today that they have acquired F•••• H••••••••• A•••••••• L•• (FHA), a leading Pharmacovigilance consultancy and long-time SSI collaborative partner. | S•• S•••••••, LLC is held by A••••• Capital Partners on it”
Side not stated
  • D••• L••••Managementconfirmed
    “D••• L••••, CEO of S•• S••••••• stated, “We are thrilled to officially welcome FHA to the SSI family.”
  • A••• S•••••••Managementconfirmed
    “A••• S•••••••, President of S•• S••••••• said, “SSI incorporates a blended team of MDs, former Chief Medical Officers and business consultants to deliver a model we believe brings the most value to our clients.”
  • F•••• H••••••••• A•••••••• L••Targetconfirmed
    “S•• S•••••••, LLC (“SSI” or the “Company”), a leading Life Sciences consultancy, announced today that they have acquired F•••• H••••••••• A•••••••• L•• (FHA), a leading Pharmacovigilance consultancy and long-time SSI collaborative partner.”
Evidence
“S•• S•••••••, LLC (“SSI” or the “Company”), a leading Life Sciences consultancy, announced today that they have acquired F•••• H••••••••• A•••••••• L•• (FHA), a leading Pharmacovigilance consultancy and long-time SSI collaborative partner.”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 16, 2026
S•• S••••••• Announces Acquisition of Long-Term Partner F•••• H••••••••• Advisors | Private Equity Intelligence | DFX